2nd Conference on Innovations in Tuberculosis 2025

The 2nd Conference on Innovations in Tuberculosis was held at the Windhoek International Convention Centre, Windhoek, Namibia on 12 May 2025, as a pre-conference to the INTEREST 2025 Conference. The conference had received COMPLIANT status from Ethical MedTech Europe platform.

To stay updated on the upcoming and related events, make sure you are signed up for our newsletter.

Tuberculosis (TB) caused 1.6 million deaths in 2021, making it the leading cause of death among infectious diseases, surpassing HIV. Yet, it is a curable and preventable disease. While a quarter of the global population has been infected, only 5-10% of infected individuals develop symptoms. The regions with the highest burden are South-East Asia, Africa, and the Western Pacific. This bacterial disease is treated with a long course of antibiotics. However, treatment options for Multidrug-resistant TB (MDR-TB) are limited, and MDR-TB remains a public health crisis and a health security threat.

TB is a priority on the global health agenda. The coordinated efforts of national and global leadership, research organizations, and civil society strive to achieve a world free of TB. However, equitable access to prevention, testing, treatment, and care remains a challenge. On the other hand, we are witnessing the emergence of encouraging new tools to curb TB. A recent study demonstrated a remarkable reduction in TB transmission due to nutritional supplements offered to household contacts, providing an evidence-based approach to addressing structural determinants of TB, such as malnutrition. On the biomedical side, a historic milestone appears to be within reach, with the late-stage clinical evaluation of a vaccine to prevent the pulmonary form of TB in adolescents and adults, developed by the Gates Foundation. In parallel, new treatment guidelines for 6-month all-oral regimens for MDR-TB offer simplified treatment options for these patients.

Despite these exciting developments and innovations, they are primarily discussed at major international meetings, which in turn offers limited opportunities for researchers and healthcare professionals from high-burden countries in Africa. This also restricts discussions tailored to regional epidemiological situations, healthcare, and societal contexts. Therefore, we proposed a platform to disseminate clinically relevant innovations and discuss their translation and implementation in Africa, considering region-specific epidemic patterns, available prevention, testing, and treatment options, and healthcare settings.

General Information 

Practical Information 

Please note that payment by credit card is required to be able to register for the conference. Please contact the conference secretariat if this is not possible for you.

If you are eligible for a discount, please contact the conference secretariat Yulia Veldhuis at yulia.veldhuis@amededu.com for the special registration code.

*Countries included in the low-income and middle-income economies list of the World Bank Classification

Important

• We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.

• Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

• The Conference on Innovations in Tuberculosis accepts new original data as well as encored abstracts. All abstracts must focus on the African region and contain up-to-date information at the time of the conference. 

• Early-career professionals and academia from Resource-Limited Settings with an accepted abstract will be offered a 50% discount on the Early Fee. The requirements for the application are specified here.

• Abstract presenters are expected to attend the workshop in-person to present their abstract.

  Please contact the workshop secretariat if this is not possible.

• Abstract submitters are strongly encouraged to use person-first language in their abstracts. View the video tutorial and guidelines here.

By submitting an abstract to a meeting organized by Virology Education BV (VE), the abstract submitter hereby agrees to the terms and conditions.

The terms and conditions can be viewed here.  

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the conference, identify interesting topics and candidate speakers, and review all submitted abstracts.

The members of Scientific Committee are hand-picked by the Organizing Committee (OC) and the conference secretariat based on their significant contributions and commitment to the field. They assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the conference as moderators and/or chairs of sessions.

• Amsalu Bekele Binegdie, MD, College of Health Sciences, Addis Ababa University, Ethiopia
• John Bimba, PhD, Bingham University, Nigeria
• Maryline Bonnet, MD, PhD, The French National Research Institute for Sustainable Development (IRD), the University of Montpellier and the National Institute of Health and Medical Research, Montpellier, France, Mbarara University of Science and Technology in MBarara, Uganda 
• Jeremiah Chakaya Muhwa, MBChB, MMeD, DThM, Kenyatta University, Respiratory Society of Kenya, Kenya 
• Novel Chegou, BMLS (Hons), BSc. Hons., PhD, Stellenbosch University, South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, South Africa
• Joel Fleury Djoba Siawaya, PhD, HDR, Mother and Child University Hospital, Gabon
• Thandi J.N Dlamini-Miti, MBBCh, Msc, Isango Lethemba TB Research Unit, Nakekelwa Medical Institute, South Africa
• Alberto García-Basteiro, MD, PhD, Barcelona Institute for Global Health (ISGlobal), Spain, Centro de Investigação em Saúde de Manhiça (CISM), Mozambique
• Norbert Heinrich, MD, LMU University Hospital, Germany
• Bouke de Jong, MD, PhD, Institute of Tropical Medicine, Belgium
• Celso Khosa, MD, PhD, Instituto Nacional de Saúde, Mozambique
• Andre Loxton, PhD, SAMRC and Stellenbosch University, South Africa
• Sayoki G Mfinanga, MD,PhD, Liverpool School Tropical Medicine, University Collage London, England, Nelson Mandela African Institution of Science and Technology (NM-AIST), The Muhimbili University of Health and Allied Sciences, Tanzania
• Lloyd Mulenga, BScHb, MBChB, MSc, MMed, PhD, Ministry of Health, Zambia
• Esther Stanslaus Ngadaya, MD, PGDHE, PhD, National Institute for Medical Research (NIMR), Kampala National University, Tanzania
• Abel Nkolo, MBChB, MPH, PhD, Africa and LAC Region, Uganda
• Nyanda Elias Ntinginya, MD, Msc, PhD, National Institute for Medical Research (NIMR), Tanzania
• Issa Sabi, MD, MMed, PhD, Mbeya Medical Research Center, National Institute for Medical Research (NIMR), Tanzania
• Simon Walusimbi, MD, MSc, PhD, Makerere University School of Public Health and Lung Institute, Uganda

• 1st Edition - Conference on Innovations in Tuberculosis 2024, Uganda, Live 

The Conference on Innovations in Tuberculosis 2025 is endorsed by societies and organizations. Their support and collaboration are key to the success of this conference!

Members or employees of endorsing organizations are eligible for a 25% discount on the registration fee for academia. Please contact your organization to obtain the applicable discount code.

If you would like your organization to endorse this workshop, please contact Yulia Veldhuis at Yulia.Veldhuis@amededu.com